Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
J Clin Oncol. 2024 Apr 20;42(12):1378-1390. doi: 10.1200/JCO.23.01159. Epub 2024 Jan 17.
J Clin Oncol. 2024.
PMID: 38232336
Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.
Shafiee S, Gelebart P, Popa M, Hellesøy M, Hovland R, Brendsdal Forthun R, Lee J, Tohyama K, Molven A, Parekkadan B, Tore Gjertsen B, Olsnes Kittang A, McCormack E.
Shafiee S, et al. Among authors: olsnes kittang a.
Br J Haematol. 2021 Apr;193(2):415-419. doi: 10.1111/bjh.17372. Epub 2021 Mar 9.
Br J Haematol. 2021.
PMID: 33686650
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite